InvestorsHub Logo
Followers 40
Posts 7682
Boards Moderated 1
Alias Born 01/04/2006

Re: None

Thursday, 02/21/2013 1:43:33 PM

Thursday, February 21, 2013 1:43:33 PM

Post# of 3
SMA REPORTED $10 Symmetry Medical misses by $0.01, misses on revs; guides FY13 EPS in-line, revs in-line (SMA) 11.18 : Reports Q4 (Dec) earnings of $0.17 per share, $0.01 worse than the Capital IQ Consensus Estimate of $0.18; revenues rose 26.2% year/year to $106.6 mln vs the $107.85 mln consensus. Gross margin was 27.1% compared to 16.4% year ago. Co continued debt reduction; leverage ratio at 3.3

Guidance:
Co issues in-line guidance for FY13, sees EPS of $0.67-0.79, excluding a negative $0.03 impact of the Medical Device Excise Tax in SG&A expense, vs. $0.77 Capital IQ Consensus Estimate; sees FY13 revs of $420-440 mln vs. $437.18 mln Capital IQ Cons